By learning from the cutting-edge nanotechnology, some nanostrategies, including markedly improving the tumor-targeting efficiency of Pt drugs (e.g., OXA, CP, and prodrugs) and delivering anti-ROS agents (e.g., antioxidant drugs and inorganic NPs), have been developed to prevent and/or treat PIPN
doi: 10.1016/j.bbrc.2023.04.111 75 MaasKMirabalSPenziasASweetnamPMEgganKCSakkasD
GLP-1 S is a GLP-1 receptor agonist the same class behind today's leading weight-management research studied for appetite control, blood-sugar regulation, and metabolic health
half-life ~4 hours route subcutaneous or oral cadence once or twice daily storage refrigerated 28-day max typical dose 250500 mcg / day cycle 412 weeks What is BPC-157
Unfortunately, based on the approach used in the study by Tan et al
It is a shorter fragment of the original peptide, which has been found to have better oral bioavailability compared to the full-length peptide